Latest news and research on all cancers and treatments, updated several times a week
“A combination of advances in medicine and a decline in smoking are reducing the mortality rates due to cancer. The effect of smoking is large because so many people do it and it is an effective road to the development of lung cancer. It is worth noting that the decrease in cancer mortality rates is in a time when the demographic profile of the population is shifting to include a larger number of older people with a greater risk of suffering cancer, as well as a concurrent rise in the number of overweight and obese individuals, a condition that is also associated with increased risk of suffering many cancers” [Note: The Lifetime Probability of Developing and Dying from Cancer, 2008-2010 shows about I chance in 2 of getting cancer for men, and 1 in 4 of dying from this; 1 in 3 for women and 1 in 5 of dying from cancer. These figures do NOT tell us what is the likelihood of dying from cancer once diagnosed. I'm not sure there is 'declining mortality', as more people are actually dying of cancer, just later; perhaps a better title would be 'longer survival once diagnosed']
The hottest area in cancer drugs is going mainstream this year. ... to modify the immune system cells and retrain them to attack blood cancers, ...
Most who get pancreatic cancer are dead within a year to 18 months. ... promising PD-1 inhibitor class that helps the immune system fight cancer.
They also noted a positive association with an increased risk of bladder cancer," the IARC stated. The IARC called air pollution the most widespread ...
Cancer News in Science Daily
Locally advanced rectal cancer patients who receive preoperative radiation therapy with either irinotecan plus capecitabine or oxaliplatin plus capecitabine have a four-year overall survival rate of 85 percent and 75 percent, respectively, according to a study.
Adding head and neck cancer screenings to newly recommended lung cancer screenings would likely improve early detection and survival, according to a multidisciplinary team led by scientists. Head and neck cancer is the world's sixth-most common type of cancer. Worldwide every year, 600,000 people are diagnosed with it and about 350,000 die. Tobacco use and alcohol consumption are the major risk factors for developing the cancer.
Partnering with head and neck surgeons, pathologists in the U.S. have developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues.
Tambahkan Komentar